Changzhou Yabang

Yabang Pharma, a subsidiary of the Yabang Investment Holding Group, is a comprehensive pharmaceutical company based in Changzhou, China, specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates several high-standard production bases that comply with global GMP requirements, including certifications from the FDA and EDQM. Its product portfolio covers a wide range of therapeutic areas such as cardiovascular, anti-infective, gastrointestinal, and antiviral treatments. Yabang Pharma is recognized as a leading domestic producer of several key APIs, including amlodipine besylate and various cephalosporins. Beyond domestic sales, the company maintains a significant international presence, exporting products to over 50 countries across Asia, Europe, and the Americas.